RESEARCHER PROFILE

Nehal Rana

University of Central Punjab

Synthesis and Characterization of Heterocyclic CompoundsSynthesis and biological activityCrystal structures of chemical compoundsCrystallography and molecular interactionsComputational Drug Discovery Methods

Nehal Rana works in Synthesis and Characterization of Heterocyclic Compounds, Synthesis and biological activity, Crystal structures of chemical compounds, Crystallography and molecular interactions, Computational Drug Discovery Methods. Recorded institutional associations include University of Central Punjab.

34Publications

323Citations

8H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

Nehal Rana

University of Central Punjab

Selected research works

Histone Modifications and their Role in Epigenetics of Cancer

Designing multi-epitope monkeypox virus-specific vaccine using immunoinformatics approach

Acyl pyrazole sulfonamides as new antidiabetic agents: synthesis, glucosidase inhibition studies, and molecular docking analysis

Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy

Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer

Synthesis, Glucosidase Inhibition, and In Silico Modeling Analysis of Highly Fluorinated 2-Imino-1,3-thiazolines in Search of Potent Antidiabetic Agents

Insight into structural topology and supramolecular assembly of tetrahydrocarbazole-carbonitrile: On the importance of noncovalent interactions and urease inhibitory profile

Synergistic effect of hydrogen bonding and C–H…π interactions to modulate the supramolecular assemblies of isobenzofuranones: X-ray crystallography, DFT analysis and antihyperglycemic potential

Analyzing the Challenges, Consequences, and Possible Treatments for Polycystic Ovary Syndrome

Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2

Therapeutic Chemoresistance in Ovarian Cancer: Emerging Hallmarks, Signaling Mechanisms and Alternative Pathways

Nanomedicines Targeting Heat Shock Protein 90 Gene Expression in the Therapy of Breast Cancer

Supramolecular networks featuring diverse array of noncovalent interactions in crystals of hydrazinylidene-benzothiazinediones: X-ray crystallographic, DFT and biochemical analysis

Hydrogen bonding, halogen bonding and C–H…π interactions governing the supramolecular architecture of 1-(4-(4-bromophenyl)piperazin-1-yl)-2-chloroethan-1-one: Insights from X-ray crystallography, DFT calculations and urease inhibitory assessment

Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19

Identification of potential inhibitors targeting yellow fever virus helicase through ligand and structure-based computational studies

Pyridylpiperazine-based carbodithioates as urease inhibitors: synthesis and biological evaluation

Discovery of bis -chalcones and bis -pyrimidines as potential urease inhibitors: from synthesis to computational insights

Mutational analysis of consanguineous families and their targeted therapy against dwarfism

Coumarin Derivatives as Potent Urease Inhibitors: In Vitro Evaluation, and Molecular Docking Studies

Preventive and Therapeutic Features of Combination Therapy for HIV

Mutational analysis of CRYAA gene of cataract and investigating risk assessment factors responsible for eye diseases in district Buner, KPK, Pakistan

CCDC 2216893: Experimental Crystal Structure Determination

The Diagnostic, Prognostic and Therapeutic Role of miRNA in the Management of Tropical Diseases

Novel indole-based sulfonate and sulfamate derivatives as potent and selective urease inhibitors targeting Helicobacter pylori: a promising therapeutic strategy